ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into health impact.
We invest and partner with founders and entrepreneurs to launch and grow global companies from Singapore. Our focus spans therapeutics, digital health and medtech, with an emphasis on first-in-class science and technology.
Our collaborative space, Node 1, provides plug-and-play spaces for ventures that have graduated from incubators to progress to their next milestones. By bringing start-ups together, we foster a vibrant and supportive community.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 79 Science Park Drive, #04-05 Cintech Iv,singapore Science Park,singapore
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- https://www.clavystbio.com/
- HQ
- Singapore
Clavystbio Questions
Clavystbio's website is https://www.clavystbio.com/
Clavystbio's LinkedIn profile is https://sg.linkedin.com/company/clavystbio
Clavystbio has
24 employees.
View email and phone details for 24
employees at Clavystbio.
Clavystbio's industry is
Investment Management
Clavystbio's top competitors are
We Venture Capital,
Lightstone Ventures,
Nsg Biolabs,
Engine Biosciences,
Tessa Therapeutics Ltd,
Mirxes,
Polaris Partners,
Paratus Sciences,
Hummingbird Bioscience,
Biotech Connection Singapore.
Clavystbio's categories are Investment Management
Clavystbio's founding year is 2022
